Neutral
Legend Biotech Corporation Announces Proposed Public Offering
Legend Biotech Corporation announced a proposed underwritten public offering of $225 million in American Depositary Shares (ADSs), with an option for ...
Neutral
Legend Biotech Corporation announced a proposed underwritten public offering of $225 million in American Depositary Shares (ADSs), with an option for ...
Neutral
Legend Biotech (NASDAQ: LEGN) has launched an underwritten public offering to sell $225 million worth of American Depositary Shares (ADSs), with each ...